Regimen

CC-11050, Auranofin, Everolimus, Vitamin D3 plus Rifabutin-modified TB Therapy

Compounds in Regimen
Description

For the combination "CC-11050, Auranofin, Everolimus, Vitamin D3 plus Rifabutin-modified TB Therapy", a Phase 2 clinical study was completed in August 2021. The Lancet publication link below and clinical trial details can be found under "Associated trials" on this page and clicking on the trial name.